It doesn’t matter to us whether they’re free, subsidised or other some other thing.
What we as an industry have been more concerned about is having a clear role for rapid testing in managing infections, in keeping the economy going and in keeping people safe.
In a sense I don’t think we really care if they are free or not in terms of supply of the tests, as long as there is a clear position from governments on the role of the tests. The industry doesn’t have a position because we sell to the government for market price and we don’t care if they are free or not.
I am on the record saying that if they were free it would improve access and equity in testing and access to tests. But that isn’t a point about market supply.